The Patent Finder

GlycoZym ApS

Also on record
Records under this name other than patents GlycoZym ApS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to GlycoZym ApS

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,635,461UDP-N-acetylglucosamine: galactose-&bgr;1, 3-N-acetylgalactosamine-&agr;-R/(GlcNAc to GalNAc) &bgr;1,6-N-acetylglucosaminyltransferase, C2GnT3
Formerly held
Term ended
Term ended Aug 24, 2020 · USPTO record
Term endedTerm ended Aug 24, 2020USPTO record
US 7,381,554UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/N-acetylglucosamine-β1,3-N-acetylgalactosamine-α-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2/4GnT
Formerly held
Lapsed on the fee record
Ended Jun 3, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 3, 2020USPTO record
US 7,338,932Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
Formerly held
Lapsed on the fee record
Ended Mar 4, 2020 · USPTO record
Lapsed on the fee recordEnded Mar 4, 2020USPTO record
US 7,374,919UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2
Formerly held
Term ended
Term ended May 5, 2019 · USPTO record
Term endedTerm ended May 5, 2019USPTO record
US 7,115,404UDP-galactose: β-D-galactose-R 4-α-D-galac-tosyltransferase, α4Gal-T1
Formerly held
Lapsed on the fee record
Ended Oct 3, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 3, 2018USPTO record
US 7,097,994UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3
Formerly held
Lapsed on the fee record
Ended Aug 29, 2018 · USPTO record
Lapsed on the fee recordEnded Aug 29, 2018USPTO record
US 7,094,887UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3
Formerly held
Lapsed on the fee record
Ended Aug 22, 2018 · USPTO record
Lapsed on the fee recordEnded Aug 22, 2018USPTO record
US 7,078,206UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GalNAc) β1,6N-acetylglucosaminyltransferase, C2GnT3
Formerly held
Lapsed on the fee record
Ended Jul 18, 2018 · USPTO record
Lapsed on the fee recordEnded Jul 18, 2018USPTO record
US 6,558,934UDP-galactose: &bgr;-N-acetyl-glucosamine &bgr;-1,4-galactosyl-transferase, &bgr;4Gal-T2
Formerly held
Term ended
Term ended Jul 17, 2018 · USPTO record
Term endedTerm ended Jul 17, 2018USPTO record
US 7,670,816UDP-galactose:β-D-galactose-R 4-α-D-galactosyltransferase, α4gal-T1
Formerly held
Lapsed on the fee record
Ended Mar 2, 2018 · USPTO record
Lapsed on the fee recordEnded Mar 2, 2018USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited